• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prostate cancer.

作者信息

Guthrie T H, Watson P

机构信息

Medical College of Georgia, Augusta.

出版信息

Am Fam Physician. 1987 Oct;36(4):217-24.

PMID:3314438
Abstract

Prostate cancer is the most frequent malignancy in elderly men. Common presentations include asymptomatic prostate nodules, unexplained bone pain or bladder outlet obstruction. Histologic grading clearly influences the prognosis. Either potency-saving subcapsular prostatectomy or radiation therapy is effective in treating localized disease. New prospects for hormonal therapy of metastatic prostate cancer include antiandrogens and gonadotropin-releasing analogs.

摘要

相似文献

1
Prostate cancer.
Am Fam Physician. 1987 Oct;36(4):217-24.
2
Hormonal therapy in prostatic carcinoma.前列腺癌的激素治疗
Urology. 1984 Nov;24(5 Suppl):18-23.
3
Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.前列腺癌初次治疗后尿道狭窄的发生率:来自CaPSURE的数据。
J Urol. 2007 Aug;178(2):529-34; discussion 534. doi: 10.1016/j.juro.2007.03.126. Epub 2007 Jun 13.
4
Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).雄激素剥夺疗法作为局限性前列腺癌的主要治疗方法:来自前列腺癌战略泌尿学研究计划(CaPSURE)的数据。
Cancer. 2006 Apr 15;106(8):1708-14. doi: 10.1002/cncr.21799.
5
The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy.
Urol Clin North Am. 1994 Nov;21(4):707-15.
6
[Correlation between re-biopsy one year after endocrine therapy and long-term prognosis in localized prostate cancer].[内分泌治疗一年后再次活检与局限性前列腺癌长期预后的相关性]
Gan To Kagaku Ryoho. 2005 Jan;32(1):57-63.
7
[What is safe in the therapy of advanced prostatic cancer?].[晚期前列腺癌治疗中的安全措施是什么?]
Internist (Berl). 1985 Dec;26(12):765-70.
8
Global update on defining and treating high-risk localized prostate cancer with leuprorelin: a USA perspective--identifying men at diagnosis who are at high risk of prostate cancer death after surgery or radiation therapy.亮丙瑞林治疗高危局限性前列腺癌的全球最新进展:美国视角——识别诊断时术后或放疗后有前列腺癌死亡高风险的男性。
BJU Int. 2007 Jan;99 Suppl 1:13-6; discussion 17-8. doi: 10.1111/j.1464-410X.2007.06594.x.
9
Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer.临床局限性前列腺癌患者在根治性前列腺切除术前行8个月新辅助雄激素剥夺治疗的生化和病理效应
J Urol. 1996 Jan;155(1):213-9.
10
Treatment options in androgen-independent prostate cancer.雄激素非依赖性前列腺癌的治疗选择。
Cancer Invest. 1999;17(2):137-44.